Literature DB >> 20353377

Peroneal neuropathy following liver transplantation: possible predisposing factors and outcome.

Ashish Singhal1, Mukul Varma, Neerav Goyal, Vivek Vij, Manav Wadhawan, Subash Gupta.   

Abstract

INTRODUCTION: Perioperative peroneal neuropathy is an uncommon complication following operations remote from the leg or in supine position including liver transplant.
MATERIALS AND METHODS: We retrospectively reviewed the medical records of 132 living-donor liver transplant recipients done at our center between September 2006 and December 2008. Various potential preoperative, intraoperative, and postoperative factors were studied in the cases that developed perioperative peroneal neuropathy.
RESULTS: Peroneal neuropathy was reported in 7 recipients (5.3%) following liver transplant. Apart from intraoperative positioning, other identifiable predisposing factors appear to be poor nutritional status, tall and slender body shape, alcoholic liver disease, and higher pretransplant model for endstage liver disease score. All patients were treated conservatively, including nutritionally balanced diet and vitamin supplements combined with physical rehabilitation therapy. The motor power returned to normal within 6 months in all 7 patients.
CONCLUSIONS: Perioperative peroneal neuropathy may be contributed by various preoperative factors apart from intraoperative nerve compression. It can be effectively prevented by being aware of the predisposing factors and implicating adequate precautions perioperatively.

Entities:  

Mesh:

Year:  2009        PMID: 20353377

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  1 in total

1.  Association between the use of gel pads under patients' knees and the incidence of peroneal neuropathy following liver transplantation.

Authors:  Gaab Soo Kim; Jin Sun Yoon; Rim Kee; Young Hee Shin; Justin Sangwook Ko; Mi Sook Gwak; Ji Hye Hwang; Suk-Koo Lee
Journal:  Singapore Med J       Date:  2014-08       Impact factor: 1.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.